Multicentric Castleman Disease of Hyaline Vascular Type Presentingas Cervical Lymphadenopathy with Systemic Inflammatory Featuresin a Young Male
Abstract
Castleman disease is a rare lymphoproliferative disorder with unicentric and multicentric forms. It can mimic tuberculosis, lymphoma, systemic lupus erythematosus and other inflammatory diseases, making diagnosis challenging. Excess interleukin-6 activity is central to many systemic manifestations, particularly in idiopathic multicentric Castleman disease. A 20-year-old male presented with a slowly enlarging left cervical swelling for two years, with rapid progression over three months, evening low-grade fever, night sweats, anorexia and 8-10 kg weight loss. Examination revealed a hard, non-tender left cervical mass. CRP and IL-6 were elevated, while autoimmune, HIV, HHV-8, viral and tuberculosis workup was negative. CT showed a left anterior cervical chain mass with hilar and inguinal lymph node involvement. Excision biopsy demonstrated hyaline vascular Castleman disease morphology. The clinicoradiological and histopathological findings supported multicentric Castleman disease, hyaline vascular type. Because siltuximab was not locally available, the patient was treated with tocilizumab 8 mg/kg intravenously every two weeks, along with tapering corticosteroids. After six doses, he achieved complete remission. This case highlights that Castleman disease should be considered in chronic cervical lymphadenopathy with constitutional symptoms after excluding infection, autoimmune disease and malignancy. Early excision biopsy, systemic staging and targeted anti-IL-6 therapy can lead to excellent clinical response in HHV-8-negative multicentric disease.
How to Cite This Article
Fatima N, Mumtaz A. Multicentric Castleman Disease of Hyaline Vascular Type Presentingas Cervical Lymphadenopathy with Systemic Inflammatory Featuresin a Young Male. J Pak Soc Intern Med. 2026;7(2):165–168. doi:10.70302/jpsim.v7i2.2634
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Sikora M, Dąbrowska-Leonik N, Buda P, Wolska-Kuśnierz B, Jahnz-Różyk K, Pac M, et al. Castleman Disease—Still More Questions than Answers: A Case Report and Review of the Literature. J Clin Med. 2025;14(8):2799.
- Iyer S, Bhatti MI, Halliday M. Castleman’s disease—A case report. Int J Surg Case Rep. 2010;1(3):25–26.
- Wang L, Chen H, Shi J, Tang H, Li H, Zheng W, et al. Castleman disease mimicking systemic lupus erythematosus: A case report. Medicine (Baltimore). 2018;97(38):e12291.
- Hu W, Kong Y, Hu B, Ai J, Zhang P. Atypical clinical presentation associated with Castleman disease: a case report and review of the literature. Front Med. 2025; 12:e1626722.
- Izuchukwu IS, Tourbaf K, Mahoney MC. An unusual presentation of Castleman’s disease: a case report. BMC Infect Dis. 2003; 3:20.
- Saadallah MAH. Castleman’s disease: A rare case report and review of literature. Int J Surg Case Rep. 2022; 95:107282.
- Eward WC, DeWitt SB, Brigman BE, Kontogeorgakos V, Lagoo AS. Extranodal Castleman disease of the extremities: a case report and review of the literature. Skeletal Radiol. 2014; 43(6):1627–31.
- Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017; 129(12):1646–57.
- Van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018; 132(20):2115–24.
- Lang E, van Rhee F. Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances. Blood Rev. 2024; 64:e101161.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.